L.B. Bohle Maschinen + Verfahren GmbH (Germany) - Despite a reserved investment climate in the pharmaceutical industry, L.B. Bohle Maschinen + Verfahren GmbH has used the 2014 financial year to prepare itself for the future – with a multi-million euro investment. The new Technology Center at its headquarters in Ennigerloh will open in March 2015. It offers customers and researchers an optimal platform for development. Owner Lorenz Bohle has also strengthened the management team. Sales Manager Tim Remmert has been promoted to the Management Board. The Board will also see greater involvement from Dr Hubertus Rehbaum (Research & Development) and Thorsten Wesselmann (Engineering).
“We might not have been able to escape the effects of the difficult market environment,” states Lorenz Bohle matter-of-factly, “but we have retained our leadership position and invested further in innovation.” At Plant 3, further progress has been made in gradually establishing lean production, meaning that production processes have been successfully optimised within a very short period of time. A sales offensive in Asia and South America, but especially in the recovered US market should see an acceleration in incoming orders across the entire product range.
Platform for knowledge transfer:
“At Interpack 2014, we presented an alternative to the Wurster process with the Bohle Uni Cone BUC® process, which coats even the smallest particles more evenly and precisely,” states Lorenz Bohle, setting store by technological advantages as part of the market campaign. The process also allows customers to apply active substances to their products with the highest precision. “Even in very complex processes, the losses are below one percent,” says Bohle.
Starting in March 2015, the Bohle Technology Center will offer customers, researchers and cooperation partners a first-class platform for the development of continuous production processes. In the new, architecturally sophisticated, high-tech building, customers will be presented with solutions for direct compression, wet granulation and dry compaction. “Significant for customers is the permanent and cross-process measuring, monitoring and controlling of production, for which we are now laying the groundwork,” states Lorenz Bohle, setting the objectives. In the designing of the innovative continuous production line in particular, Bohle sees great potential for growth.
The company owner has also laid the foundations for the future with regard to personnel. “Beginning 1 January 2015, our long-term Sales Manager Tim Remmert will be more involved in strategic activities,” explains Lorenz Bohle. In addition, Manager Scientific Operations Dr Hubertus Rehbaum has joined the executive ranks as an assistant to the Management Board. Thorsten Wesselmann has taken on the role of Head of Engineering. Armin Bohle resigned from his operational activities with the company at his own request in October 2014, but will continue to support the development of the company as a shareholder.
Growth course firmly in sight:
The financial situation of L.B. Bohle Maschinen + Verfahren GmbH remains solid in 2014. “Our equity ratio remains at 50 percent,” reports Lorenz Bohle. Investments will be financed through current operations. “With the drive in America and with the team and potential cooperation partners, we consider ourselves to be solidly positioned for 2015, a year in which we will face considerable challenges owing to the Interphex and ACHEMA trade fairs and the opening of the Technology Center.” As a goal he has set his sights firmly on a return to the growth rates of previous years.
About L.B. Bohle Maschinen + Verfahren GmbH:
L.B. Bohle Maschinen + Verfahren GmbH is a global acting manufacturer for the pharmaceutical industry. The range of products includes process and handling equipment for the pharmaceutical solids production.
For instance, film coater, blending systems, fluid bed systems, single pot and high shear granulators, dry granulator, handling systems and much more were successfully planned and built by LBB. The German engineering company also creates laboratory equipment for the research and development units of its clients. A large number of well-known multi nationals belong to the group of satisfied LBB customers.
In 2005, the L.B. Bohle Service Center was established. This well-equipped area offers the opportunity to operate the Bohle systems for trials and tests. The production sequences can be tested under actual GMP conditions.
L.B. Bohle was founded in 1981 by Mr. Lorenz Bohle. The founder is owner and managing director of the company. Since more than 30 years, Mr. Bohle and his team live and work according the corporate philosophy: “Always to be better than the market.”
The headquarters are located in Ennigerloh, Germany. About 230 specialists build a highly qualified team. The manufacturer has subsidiaries in Sassenberg and Ennigerloh (Plant 2 and Plant 3), Germany, L.B. Bohle LLC, in Warminster, PA, USA and L.B. Bohle India Private Ltd. in Goa, India. The company has one representative office in Shanghai. Furthermore, the company is represented all over the world in about 35 countries by independent sales agencies.